The Role of Genetics in Sporadic GEP-NETs: A Comprehensive Review of the Literature
References
- Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1: 238-239.14000847
- Yao JC, Hassan M, Phan A et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825cases in the United States. J Clin Oncol. 2008; 26: 3063-30721856589410.1200/JCO.2007.15.4377
- https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf
- Niklas Gebauer, Christian Schmidt-Werthern, Veronica Bernard et al.Genomic landscape of pancreatic neuroendocrine tumors. World J Gastroenterol 2014 December 14; 20(46): 17498-175062551666410.3748/wjg.v20.i46.17498
- Joakim Crona, Britt Skogseid. Genetics of neuroendocrine tumors. European Journal of Endocrinology(2016) 174, R275–R290
- Ken-Shwo Dai, Wei Wei, Choong-Chin Liew. Molecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ Domain. Biochemical and Biophysical Research Communications 273, 991– 996 (2000)10.1006/bbrc.2000.305310891360
- Pérez-Magán E, Rodríguez de Lope A, Ribalta T et al. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro Oncol 2010; 12: 1278-12902068572010.1093/neuonc/noq081
- Jen J1, Lin LL2, Chen HT3 et al. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene,2016 May 5;35(18):2357-692627930410.1038/onc.2015.296
- Aragane H, Sakakura C, Nakanishi M et al. Chromosomal aberrations in colorectal cancersand liver metastases analyzed by comparative genomic hybridization. Int J Cancer 2001; 94: 623-6291174545510.1002/ijc.1522
- Schmidt H, Taubert H, Würl P et al. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes Cancer 2002; 34: 69-7710.1002/gcc.1003611921284
- Hale JS, Li M, Sinyuk M, Jahnen-Dechent W et al. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesisand growth. PLoS One 2012; 7: e4003310.1371/journal.pone.0040033
- May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18 (53): 7621–361061870210.1038/sj.onc.1203285
- Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137: 413-4311941054010.1016/j.cell.2009.04.037
- Marinoni I, Kurrer AS, Vassella E et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 2014, 146, 453–460.10.1053/j.gastro.2013.10.02024148618
- Lovejoy CA, Li W, Reisenweber S et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genetics 2012 8.
- Jonkers YM, Claessen SM, Perren A et al. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine-Related Cancer 2007 14 769–779.10.1677/ERC-07-011117914106
- Guertin DA, Sabatini DM . Defining the role of mTOR in cancer. Cancer Cell 2009, 12 (1): 9–22.
- Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays. 2002 Apr;24(4):362-70.10.1002/bies.1006811948622
- Li YX, Jin HG, Yan CG et al. Molecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene. Mol Biol Rep. 2014 Jun;41(6):3561-810.1007/s11033-014-3167-924797538
- Sacchetti P, Carpentier R, Ségard P et al. Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1. Nucleic Acids Res. 2006;34(19):5515-2710.1093/nar/gkl71217020917
- Lee D, Sohn H, Kalpana GV et al. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399 (6735): 487–91036596310.1038/20966
- Le Tourneau C, Paoletti X, Servant N, et al. Randomised proof-of-conceptphase II trial comparing targeted therapy based on tumour molecularprofiling vs conventional therapy in patients with refractory cancer: results ofthe feasibility part of the SHIVA trial. Br J Cancer. 2014; 111: 17-24.10.1038/bjc.2014.211
- Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007 26 (57): 7825–32.10.1038/sj.onc.121059417599048
- Knowles PP, Murray-Rust J, Kjaer S et al. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem. 2006 Nov 3;281(44):33577-871692868310.1074/jbc.M605604200
- Xiao-Ping Qi,1,* Ju-Ming Ma,1 Zhen-Fang Du et al. RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family. PLoS One. 2011; 6(5): e20353.10.1371/journal.pone.0020353
- Park C, Ha SY, Kim ST et al. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors. Oncotarget. 2016 Jan 26;7(4):4024-3510.18632/oncotarget.660226684240
- Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 1991 Sep 20;66(6):1197-206.183306610.1016/0092-8674(91)90042-W
Language: English
Page range: 1 - 5
Submitted on: Nov 28, 2016
Accepted on: May 14, 2017
Published on: Jun 30, 2017
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2017 George Fotopoulos, Ioannis Vathiotis, George C. Nikou, Konstantinos Syrigos, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.